BIRMINGHAM, Ala., and KISSIMMEE, Fla., May 7, 2024 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Kissimmee, a 50-bed inpatient rehabilitation hospital located at 4950 Calypso Cay Way. The hospital serves patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.
In addition to 24-hour registered nursing care, Encompass Health of Kissimmee offers physical, occupational and speech therapies to restore functional ability and quality of life. Care is provided by highly specialized nurses, therapists and physicians. The hospital features all private patient rooms, a large therapy gym with advanced rehabilitation technologies and an activities of daily living suite, a therapy courtyard, a cafeteria and a dayroom.
"We are honored to open this rehabilitation hospital to help individuals in the community recovering from major illnesses and injuries regain the strength and function to return back to what matters most," said Amanda Atkinson, CEO of Encompass Health Rehabilitation Hospital of Kissimmee. "Our dedicated team of experts will provide specialized care, close to home at this state-of-the-art hospital. We are excited to have the opportunity to serve as the region's trusted choice for rehabilitation."
Encompass Health Rehabilitation Hospital of Kissimmee is Encompass Health's 161st inpatient rehabilitation hospital nationwide and its 21st inpatient rehabilitation hospital in Florida.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 161 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Encompass Health Media Contact:
Kennedi Spurling | 205-970-5912
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$100.23 |
| Daily Change: | -1.11 -1.10 |
| Daily Volume: | 776,330 |
| Market Cap: | US$10.090B |
November 04, 2024 October 28, 2024 August 05, 2024 July 30, 2024 July 08, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
